Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Norepinephrine for Radiodermatitis in Breast Cancer
NCT01544504Phase 2Withdrawn
- Sponsor
- ProCertus BioPharm
- Start
- Mar 2012
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of norepinephrine in radiodermatitis, sponsored by ProCertus BioPharm. Planned start Mar 2012; status: withdrawn.
02
Drugs
norepinephrine
03
Conditions
radiodermatitis
Beyond the preview
Go deeper on NCT01544504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01544504.